Norway Savings Bank’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-31
Closed -$15.9K 181
2022
Q4
$15.9K Hold
31
0.01% 232
2022
Q3
$14K Hold
31
0.01% 236
2022
Q2
$15K Hold
31
0.01% 238
2022
Q1
$15K Hold
31
0.01% 246
2021
Q4
$14K Hold
31
0.01% 248
2021
Q3
$12K Hold
31
0.01% 262
2021
Q2
$12K Buy
+31
New +$11.8K 0.01% 265

Other funds holding ELV

Norway Savings Bank's ELV Position: Q1 2023 in Review

Norway Savings Bank sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 31 shares — an estimated $15.9K sold.

Norway Savings Bank first reported a position in ELV in Q2 2021 and held it in 7 quarters. The position peaked at $15.9K in Q4 2022. 1,516 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

  • Norway Savings Bank reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
  • Norway Savings Bank sold 31 Elevance Health shares in Q1 2023, an estimated $15.9K.
  • Norway Savings Bank first reported a position in Elevance Health in Q2 2021 and held it in 7 quarters.
  • Norway Savings Bank's Elevance Health position peaked at $15.9K in Q4 2022.
  • 1,516 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on Norway Savings Bank's 13F filing for Q1 2023, filed 11 Apr 2023.